| Drop-out from addiction treatment: A systematic review of risk factors HH Brorson, EA Arnevik, K Rand-Hendriksen, F Duckert Clinical psychology review 33 (8), 1010-1024, 2013 | 722 | 2013 |
| Estimating an EQ-5D-5L value set for China N Luo, G Liu, M Li, H Guan, X Jin, K Rand-Hendriksen Value in Health 20 (4), 662-669, 2017 | 472 | 2017 |
| Overview, update, and lessons learned from the international EQ-5D-5L valuation work: version 2 of the EQ-5D-5L valuation protocol E Stolk, K Ludwig, K Rand, B van Hout, JM Ramos-Goñi Value in Health 22 (1), 23-30, 2019 | 279 | 2019 |
| EuroQol protocols for time trade-off valuation of health outcomes M Oppe, K Rand-Hendriksen, K Shah, JM Ramos‐Goñi, N Luo Pharmacoeconomics 34, 993-1004, 2016 | 238 | 2016 |
| Ideology and power: The influence of current neo‐liberalism in society HE Nafstad, RM Blakar, E Carlquist, JM Phelps, K Rand‐Hendriksen Journal of community & applied social psychology 17 (4), 313-327, 2007 | 158 | 2007 |
| Globalization, neo-liberalism and community psychology HE Nafstad, RM Blakar, E Carlquist, JM Phelps, K Rand-Hendriksen American journal of community psychology 43, 162-175, 2009 | 92 | 2009 |
| Norwegian population norms for the EQ-5D-5L: results from a general population survey AM Garratt, TM Hansen, LA Augestad, K Rand, K Stavem Quality of Life Research, 1-10, 2021 | 75 | 2021 |
| Choice defines QALYs: a US valuation of the EQ-5D-5L BM Craig, K Rand Medical Care 56 (6), 529-536, 2018 | 66 | 2018 |
| EQ-5D-5L valuation for the Malaysian population AA Shafie, A Vasan Thakumar, CJ Lim, N Luo, K Rand-Hendriksen, ... Pharmacoeconomics 37, 715-725, 2019 | 64 | 2019 |
| General population norms for the EQ-5D-3 L in Norway: comparison of postal and web surveys K Stavem, LA Augestad, IS Kristiansen, K Rand Health and quality of life outcomes 16, 1-10, 2018 | 63 | 2018 |
| What should I trust? Individual differences in attitudes to conflicting information and misinformation on COVID-19 P Filkuková, P Ayton, K Rand, J Langguth Frontiers in psychology 12, 588478, 2021 | 42 | 2021 |
| Valuation of EQ-5D-3l health states in Slovenia: VAS based and TTO based value sets VP Rupel, A Srakar, K Rand Slovenian Journal of Public Health 59 (1), 8-17, 2020 | 42 | 2020 |
| Quality-adjusted life-years without constant proportionality BM Craig, K Rand, H Bailey, PFM Stalmeier Value in Health 21 (9), 1124-1131, 2018 | 41 | 2018 |
| Comparison of hypothetical and experienced EQ-5D valuations: relative weights of the five dimensions K Rand-Hendriksen, LA Augestad, IS Kristiansen, K Stavem Quality of Life Research 21, 1005-1012, 2012 | 41 | 2012 |
| Less is more: cross-validation testing of simplified nonlinear regression model specifications for EQ-5D-5L health state values K Rand-Hendriksen, JM Ramos-Goñi, LA Augestad, N Luo Value in Health 20 (7), 945-952, 2017 | 34 | 2017 |
| The remarkably frequent use of EQ-5D in non-economic research A Wang, K Rand, Z Yang, R Brooks, J Busschbach The European Journal of Health Economics, 1-8, 2022 | 33 | 2022 |
| Communal values and individualism in our era of globalization: A comparative longitudinal study of three different societies HE Nafstad, RM Blakar, A Botchway, ES Bruer, P Filkukova, ... Well-Being and Cultures, 51-69, 2013 | 32 | 2013 |
| Valuing EQ-5D-Y: the current state of play N Devlin, T Pan, S Kreimeier, J Verstraete, E Stolk, K Rand, M Herdman Health and Quality of Life Outcomes 20 (1), 105, 2022 | 28 | 2022 |
| Valuation of health states considered to be worse than death—an analysis of composite time trade-off data from 5 EQ-5D-5L valuation studies M Gandhi, K Rand, N Luo Value in Health 22 (3), 370-376, 2019 | 28 | 2019 |
| Learning effects in time trade-off based valuation of EQ-5D health states LA Augestad, K Rand-Hendriksen, IS Kristiansen, K Stavem Value in Health 15 (2), 340-345, 2012 | 27 | 2012 |
Koonal ShahNational Institute for Health and Care ExcellenceEmail verificata su nice.org.uk